If the demonstration that caps monthly insulin costs works, CMS might run similar demos for other drugs, Center for Medicare and Medicaid Innovation Center Director Brad Smith said Friday (Oct. 16). “We believe if the mechanism in this coverage gap works for insulin there's a good chance this may work for other drugs in the future,” Smith said while speaking at the Better Medicare Alliance Summit. Smith did not say which drugs might be candidates for future demos, and HHS...